Drug Research
Kyn Therapeutics Enters into Global Strategic Collaboration with Celgene to Develop Immuno-oncology Therapies
Kyn Therapeutics, a clinical-stage biotechnology company advancing research into new immunometabolic therapies for treating cancer, announced it has entered into a global strategic collaboration with Celgene Corporation. The goal of the collaboration is to develop novel...
Drug Research
Branched-Chain Amino Acids Found to Regulate the Development and Progression of Cancer
Researchers at A*STAR's Singapore Bioimaging Consortium (SBIC) have discovered that branched-chain amino acids (BCAAs) in tumours can be targeted to prevent and treat cancer. Together with collaborators from the United States and National Cancer Centre Singapore...
Drug Research
Regeneron and Sanofi Restructure Immuno-Oncology Collaboration for Discovery and Development Programs
Regeneron Pharmaceuticals, Inc. and Sanofi have restructured their global Immuno-oncology Discovery and Development Agreement for new immuno-oncology cancer treatments. The 2015 Agreement was scheduled to end in approximately mid-2020, and this revision provides for ongoing collaborative...
Drug Research
GENFIT and LabCorp Sign a Licensing Agreement to Expand Access to a Diagnostic Assay for Non-Alcoholic SteatoHepatitis
LabCorp, a leading global life sciences company, and GENFIT , a biopharmaceutical company focused on discovering and developing drug candidates and diagnostic solutions targeting liver diseases, have announced the signing of a licensing agreement between GENFIT and Covance, LabCorp’s...
Drug Research
Propanc Biopharma Commences Drug Discovery Research Collaboration
Propanc Biopharma, Inc , a clinical stage biopharmaceutical company focused on development of new and proprietary treatments for cancer patients suffering from solid tumors such as pancreatic, ovarian and colorectal cancers, announced that a cooperation agreement has been entered...
Drug Research
Stem Cell Medicine Licenses Exosome Technology for Treating Autism from Ramot at Tel Aviv University
Stem Cell Medicine Ltd. (SCM), a biotechnology company developing new therapies for neurological indications, including mesenchymal stem cells and anti-BMP molecules for the treatment of Multiple Sclerosis, and gene therapy for the treatment of neuropathic pain, has licensed an...
Articles
Injecting New Blood into the Life Sciences Innovation Process
Innovation and collaboration are the lifeblood of the life sciences. Without them, both research and business come to a standstill.
Knowing this, how do pharmaceutical and biotechnology companies get the blood pumping, communicate their position to the marketplace as well...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
